It’s common knowledge that the Emergency Use Authorization (
EUA) of the deadly COVID-19 jabs would not have been possible if any alternative treatments for SARS-CoV-2 were available. With that in mind, the intentional
war against repurposed drugs to treat COVID—specifically
Hydroxychloroquine (HCQ) and
Ivermectin (IVM)—will no doubt be unending and always deceptive. The latest such attack appears in a February 2024 Biomedicine and Pharmacotherapy publication claiming that during the first wave of COVID-19, off-label use of HCQ resulted in an 11 percent increase in the mortality rate, resulting in 16,990 deaths in six countries. Cutting to the core of its objective—which is undoubtedly to ensure affordable drugs like HCQ aren’t used in
future pandemics—the study declares:
“These findings illustrate the hazard of drug repurposing with low-level evidence for the management of future pandemics.”
The study,
titled “Deaths induced by compassionate use of hydroxychloroquine during the first COVID-19 wave: an estimate,”
cites a meta-analysis published in 2021 in Nature, which the study authors used to estimate the number of deaths they claim were caused by HCQ. The recent study reports that “the toxicity of HCQ in patients with COVID-19 is partially due to cardiac side effects,” as referenced in the 2020
RECOVERY trial titled “Effect of Hydroxychloroquine in hospitalized patients with COVID-19.” Not surprisingly, that trial
was funded by the Bill and Melinda Gates Foundation,
Wellcome Trust, and Oxford University, among others, all components of the same sinister group profiting from and incessantly promoting the contaminated gene-damaging mRNA jabs while discrediting existing affordable drugs and cautioning of
future pandemics.
Maybe worth considering chloroquine for C19
https://t.co/LEYob7Jofr
— Elon Musk (@elonmusk)
March 16, 2020